调脉合剂对阵发房颤合并稳定性冠心病患者心率变异性及房颤负荷的影响

李腾飞; 张大炜; 田伟; 戴梅; 韩垚

doi:10.3969/j.issn.2095-6606.2023.05.007

您当前的位置：

首页 >

文章列表页 >

调脉合剂对阵发房颤合并稳定性冠心病患者心率变异性及房颤负荷的影响

临床研究 | 更新时间：2023-10-12

- 调脉合剂对阵发房颤合并稳定性冠心病患者心率变异性及房颤负荷的影响
- Influence of Tiaomai Mixture on heart rate variability and AF burden in patients with paroxysmal atrial fibrillation and stable coronary heart disease
- 现代中医临床 2023年30卷第5期页码：35-39
- 作者机构：
  
  首都医科大学附属北京中医医院　北京　100010
- 作者简介：
  
  李腾飞，男，硕士，主治医师
  # 韩垚，女，博士，副主任医师，E-mail：hanyao1212@126.com
- 基金信息：
  
  北京中医药科技发展资金项目(QN2016－16)
- DOI：10.3969/j.issn.2095-6606.2023.05.007
  中图分类号： R256.2
- 纸质出版日期：2023-09-30，
  
  收稿日期：2022-10-29，
- 稿件说明：
移动端阅览
李腾飞, 张大炜, 田伟, 等. 调脉合剂对阵发房颤合并稳定性冠心病患者心率变异性及房颤负荷的影响[J]. 现代中医临床, 2023,30(5):35-39.

LI Tengfei, ZHANG Dawei, TIAN Wei, et al. Influence of Tiaomai Mixture on heart rate variability and AF burden in patients with paroxysmal atrial fibrillation and stable coronary heart disease[J]. Modern Chinese Clinical Medicine, 2023,30(5):35-39.
李腾飞, 张大炜, 田伟, 等. 调脉合剂对阵发房颤合并稳定性冠心病患者心率变异性及房颤负荷的影响[J]. 现代中医临床, 2023,30(5):35-39. DOI： 10.3969/j.issn.2095-6606.2023.05.007.

LI Tengfei, ZHANG Dawei, TIAN Wei, et al. Influence of Tiaomai Mixture on heart rate variability and AF burden in patients with paroxysmal atrial fibrillation and stable coronary heart disease[J]. Modern Chinese Clinical Medicine, 2023,30(5):35-39. DOI： 10.3969/j.issn.2095-6606.2023.05.007.

摘要

目的

观察调脉合剂对阵发性心房颤动合并稳定性冠心病气阴两虚证患者心率变异性及房颤负荷的影响。

方法

采用随机平行对照临床试验，将56例阵发性心房颤动合并稳定性冠心病证属气阴两虚证的患者，随机分组，治疗组30例，对照组26例，2组患者均予常规基础治疗，在此基础上，治疗组患者联合调脉合剂，2组患者均连续治疗4周。对比2组患者心率变异性、房颤负荷及中医证候疗效指标。

结果

经治疗后，2组患者记录全程NN间期的标准差(standard deviation of N-N intervals

SDNN)，相邻NN间期之差的均方根(mean square of successive differences

RMSSD)，高频率范围内NN间期变异(high frequency，HF)均非常明显升高(

0.01)，组间比较差异有统计学意义(

0.01)。LF/HF，房颤负荷均非常明显降低，组间比较差异具有统计学意义(

0.05)；中医证候疗效方面，治疗组总有效率90.0%，对照组总有效率61.5%，治疗组中医症状改善方面，明显优于对照组(

0.05)。

结论

调脉合剂可以提高阵发性心房颤动合并稳定性冠心病气阴两虚证患者迷走神经功能，调节患者自主神经功能平衡，降低房颤负荷，且疗效可靠，无严重不良反应。

Abstract

Objective

To observe the effect of Tiaomai Mixture (Pulse-Regulating Mixture) on heart rate variability and AF burden in patients with paroxysmal AF (PAF) with qi-yin deficiency syndrome and stable coronary heart disease (SCAD).

Methods

In a randomized

controlled

parallel trial

56 patients with PAF

qi-yin deficiency syndrome

and SCAD were randomly divided into 30 in the control group and 26 in the treatment group. Both groups received basic routine treatment

while the treatment group was given additional Tiaomai Mixture. The treatment lasted four weeks. Heart rate variability index

AF burden

TCM syndrome score and adverse reactions were observed.

Results

Heart rate variability indexes

SDNN

RMSSD and HF were improved in both two groups (

0.01)

and the treatment group showed better improvement than the control group (

0.01). LF/HF and AFB decreased significantly in both two groups (

0.05)

and there was significant difference between the two groups (

0.05). In terms of TCM syndrome scores

the total effective rate was 90.0% in treatment group and 61.5% in the control group. The result in the treatment group were superior to those in the control group (

0.05).

Conclusion

Tiaomai Mixture is effective in improving the vagus nerve function

regulating autonomic nerve function and reducing the atrial fibrillation load in patients with paroxysmal AF with qi-yin deficiency syndrome and stable coronary heart disease. No serious adverse reactions.

关键词

调脉合剂心率变异性房颤负荷阵发性心房颤动稳定性冠心病气阴两虚证

Keywords

Tiaomai mixtureatrial fibrillation burdenheart rate variabilityparoxysmal atrial fibrillationstable coronary heart diseaseqi-yin deficiency

references

葛均波，徐永健，王辰，等. 内科学[M]. 北京：人民卫生出版社, 2018.

中华医学会心电生理和起搏分会，中国医师协会心律学专业委员会，中国房颤中心联盟心房颤动防治专家工作委员会. 心房颤动：目前的认识和治疗建议(2021) [J]. 中华心律失常学杂志, 2022, 26(1): 15-88.

董敏，邹彤，何清华，等.冠心病合并心房颤动患者的治疗及临床结局分析[J].中国心血管病研究, 2021, 19(3): 208-213.

ELSAYEDZS ，SAFFORD MM, PAUL MUNTNER，et al. Atrial Fibrillation and the Risk of Myocardial Infarction[J]. JAMA Internal Medicine, 2014, 174(1): 107-114.

SAIGUSAR , WINKELSH ，LEY K.Tcell subsets and functions in atherosclerosis[J].Nature Rev Cardi, 2020, 17(7) : 387-401.

SHARMAM , SCHLEGELMP , AFONSO MS，et al.Regulatory T Cells License Macrophage Pro-Resolving Functions During Atheroscle rosis Regression[J].Circulation Research, 2020, 127(3) : 335-353.

王斌，李毅，韩雅玲.稳定性冠心病诊断与治疗指南 [J]. 中华心血管病杂志, 2018, 46(9): 680-694.

郑筱萸. 中药新药临床研究指导原则(试行)[M]. 北京：中国医药科技出版社, 2002.

SEANDP , SAMUELIB ，KARENC ，et al.Atrialbranchartery stenosisasamechanismforatrialfibrillation[J]. Heart Rhythm, 2022, 19(8): 1237-1244.

曾学寨，刘德平，董榕，等. 自主神经在阵发性心房颤动发生中的作用[J]. 临床心电学杂志, 2007(3): 183-186.

KIMDT , LAIAC , HWANGC ，et al.The ligament of Marshall：a structural analysis in human hearts with implications for atrial arrhythmias[J].J Am Coll Cardiol, 2000, 36(4): 1324-1327.

刘志华. 自主神经系统与心律失常[J].中国心脏起搏与心电生理杂志, 2005, 19(2): 83-88.

陈尔冬，周菁.心率变异性的研究及应用进展[J].心血管病学进展, 2014, 35(4): 435-439.

KLEIGERRE ，STEINPL ，BIGGERJT .Heart rate variability：measurement and clinical utility[J].Ann Noninvasive Electrocardiol, 2005, 10(1): 88-101.

JANUARYCT ，WANNLS ，ALPERTJS ，et al.2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[J].J Am Coll Cardiol, 2014, 64(21): e1-e76.

CHEN LY，SOTOODEHNIAN , LOPEZFL ，et al. Atrial fibrillation and the risk of sudden cardiacdeath: the Atherosclerosis Risk in Communities Study and Cardiovascular Health Study[J].JAMA Intern Med, 2013, 173: 29-35.

PANDEYA ，KIM S，MOOREC ，et al.Predictors and prognostic implications of incident heart failure in patients with prevalent atrial fibrillation[J]. JACC Heart Fail, 2017, 5(1): 44-52.

TURAKHIAMP , ZIEGLERPD ，SCHMITTSK ，et al. Atrial fibrillation burden and short-term risk of stroke: case-crossover analysis of continuously recorded heart rhythm from cardiac electronic implanted devices[J]. Circ Arrhythm Electrophysiol, 2015, 8(5): 1040-1047.

CHEN LY，AGARWALSK ，NORBYFL , et al. Persistent but not paroxysmal atrial fibrillation is independently associated with lower cognitive function: ARIC study[J]. J Am Coll Cardiol, 2016, 67(11): 1379-1380.

高翔，于美丽，李金根，等.徐浩教授从“虚”“瘀”“风”论治阵发性房颤经验浅析[J].中西医结合心脑血管病杂志, 2016, 14(15): 1813-1815.

吕新会，李军，史玮，等.冠心病合并非瓣膜性房颤患者228例中医证候要素分布特征[J].世界中医药, 2017, 12(3): 661-665.

吕新会，史玮，武佶，等.中国中医科学院广安门医院心内科治疗冠心病合并非瓣膜性房颤组方规律分析[J]. 北京中医药, 2017, 36(3): 201-205.

梁晋普，王亚红，帅东亚.郭维琴教授辨治心律失常经验[J].现代中医临床, 2016, 23(5): 5-10.

戴梅，周旭升，韩垚，等. 清凉滋补调脉汤治疗阵发性房颤的疗效观察[J]. 北京中医药, 2015, 34(3): 182-184.

韩垚，秦田雨，刘红旭，等. 调脉饮及其拆方对快速性心律失常大鼠模型心肌L型钙通道β2亚基表达的影响[J].中国实验方剂学杂志, 2018, 24(20): 123-128.

李璐，赵明，魏执真，等. 调脉饮颗粒抗心律失常的多种离子通道靶点作用研究[J]. 环球中医药, 2020, 13(7): 1150-1157.

浏览量

268

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据